Millions of Migraine Attacks, Many Answers, More Questions

Millions of Migraine Attacks, Many Answers, More Questions

In the landscape of migraine treatment, many unanswered questions remain-particularly, which medications are most effective as acute agents and for which patients? Given the heterogeneity of patients, clinicians' practice, and the integration of new agents into migraine care, this is an ambitio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2023-12, Vol.101 (24), p.1089-1090
Hauptverfasser: Friedman, Sarah A, Robbins, Matthew S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1090
container_issue 24
container_start_page 1089
container_title Neurology
container_volume 101
creator Friedman, Sarah A
Robbins, Matthew S
description In the landscape of migraine treatment, many unanswered questions remain-particularly, which medications are most effective as acute agents and for which patients? Given the heterogeneity of patients, clinicians' practice, and the integration of new agents into migraine care, this is an ambitious question to address. At the same time, this question is crucial both because proper acute treatment is an important metric of quality of care and such treatments are woefully underused in the general population. .
doi_str_mv 10.1212/WNL.0000000000208084
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2895703087</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2895703087</sourcerecordid><originalsourceid>FETCH-LOGICAL-c256t-e8ceba9b37828599e9884a49d9fb10742f277a46332f447f21b8b487c4c8c16c3</originalsourceid><addsrcrecordid>eNpdkMlOwzAQhi0EoqXwBgjlyIEUb4nH3KKqLFIDQgLBzXJcGwWyFDsV6tuTqKUH5jKa5Z9f8yF0TvCUUEKv3x4XU7wPigEDP0BjktA0Thl9P0Tjvg0xAwEjdBLCJ8b9UMhjNGKAGWYyHaObvKyqsm1C1LooLz-8LhsbZV2nzVe4inLdbKKsCT_WD1XrbfS8tqEbFKfoyOkq2LNdnqDX2_nL7D5ePN09zLJFbGiSdrEFYwstCyaAQiKllQBcc7mUriBYcOqoEJqnjFHHuXCUFFBwEIYbMCQ1bIIut3dXvv0ezFVdBmOrSje2XQdFQSai_wdEv8q3q8a3IXjr1MqXtfYbRbAaqKmemvpPrZdd7BzWRW2Xe9EfJvYLk5Jl5g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2895703087</pqid></control><display><type>article</type><title>Millions of Migraine Attacks, Many Answers, More Questions</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Friedman, Sarah A ; Robbins, Matthew S</creator><creatorcontrib>Friedman, Sarah A ; Robbins, Matthew S</creatorcontrib><description>In the landscape of migraine treatment, many unanswered questions remain-particularly, which medications are most effective as acute agents and for which patients? Given the heterogeneity of patients, clinicians' practice, and the integration of new agents into migraine care, this is an ambitious question to address. At the same time, this question is crucial both because proper acute treatment is an important metric of quality of care and such treatments are woefully underused in the general population. .</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000208084</identifier><identifier>PMID: 38030396</identifier><language>eng</language><publisher>United States</publisher><ispartof>Neurology, 2023-12, Vol.101 (24), p.1089-1090</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c256t-e8ceba9b37828599e9884a49d9fb10742f277a46332f447f21b8b487c4c8c16c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38030396$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Friedman, Sarah A</creatorcontrib><creatorcontrib>Robbins, Matthew S</creatorcontrib><title>Millions of Migraine Attacks, Many Answers, More Questions</title><title>Neurology</title><addtitle>Neurology</addtitle><description>In the landscape of migraine treatment, many unanswered questions remain-particularly, which medications are most effective as acute agents and for which patients? Given the heterogeneity of patients, clinicians' practice, and the integration of new agents into migraine care, this is an ambitious question to address. At the same time, this question is crucial both because proper acute treatment is an important metric of quality of care and such treatments are woefully underused in the general population. .</description><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpdkMlOwzAQhi0EoqXwBgjlyIEUb4nH3KKqLFIDQgLBzXJcGwWyFDsV6tuTqKUH5jKa5Z9f8yF0TvCUUEKv3x4XU7wPigEDP0BjktA0Thl9P0Tjvg0xAwEjdBLCJ8b9UMhjNGKAGWYyHaObvKyqsm1C1LooLz-8LhsbZV2nzVe4inLdbKKsCT_WD1XrbfS8tqEbFKfoyOkq2LNdnqDX2_nL7D5ePN09zLJFbGiSdrEFYwstCyaAQiKllQBcc7mUriBYcOqoEJqnjFHHuXCUFFBwEIYbMCQ1bIIut3dXvv0ezFVdBmOrSje2XQdFQSai_wdEv8q3q8a3IXjr1MqXtfYbRbAaqKmemvpPrZdd7BzWRW2Xe9EfJvYLk5Jl5g</recordid><startdate>20231212</startdate><enddate>20231212</enddate><creator>Friedman, Sarah A</creator><creator>Robbins, Matthew S</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20231212</creationdate><title>Millions of Migraine Attacks, Many Answers, More Questions</title><author>Friedman, Sarah A ; Robbins, Matthew S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c256t-e8ceba9b37828599e9884a49d9fb10742f277a46332f447f21b8b487c4c8c16c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Friedman, Sarah A</creatorcontrib><creatorcontrib>Robbins, Matthew S</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Friedman, Sarah A</au><au>Robbins, Matthew S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Millions of Migraine Attacks, Many Answers, More Questions</atitle><jtitle>Neurology</jtitle><addtitle>Neurology</addtitle><date>2023-12-12</date><risdate>2023</risdate><volume>101</volume><issue>24</issue><spage>1089</spage><epage>1090</epage><pages>1089-1090</pages><issn>0028-3878</issn><eissn>1526-632X</eissn><abstract>In the landscape of migraine treatment, many unanswered questions remain-particularly, which medications are most effective as acute agents and for which patients? Given the heterogeneity of patients, clinicians' practice, and the integration of new agents into migraine care, this is an ambitious question to address. At the same time, this question is crucial both because proper acute treatment is an important metric of quality of care and such treatments are woefully underused in the general population. .</abstract><cop>United States</cop><pmid>38030396</pmid><doi>10.1212/WNL.0000000000208084</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2023-12, Vol.101 (24), p.1089-1090
issn 0028-3878
1526-632X
language eng
recordid cdi_proquest_miscellaneous_2895703087
source Journals@Ovid Complete; Alma/SFX Local Collection
title Millions of Migraine Attacks, Many Answers, More Questions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T13%3A34%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Millions%20of%20Migraine%20Attacks,%20Many%20Answers,%20More%20Questions&rft.jtitle=Neurology&rft.au=Friedman,%20Sarah%20A&rft.date=2023-12-12&rft.volume=101&rft.issue=24&rft.spage=1089&rft.epage=1090&rft.pages=1089-1090&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000208084&rft_dat=%3Cproquest_cross%3E2895703087%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2895703087&rft_id=info:pmid/38030396&rfr_iscdi=true